GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Glo... ( TBWA assigned alli and Smoking Contro...)

GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands

Date:6/3/2009

TBWA assigned alli and Smoking Control

Grey assigned US brands TUMS, Citrucel and FiberChoice

PITTSBURGH, June 3 /PRNewswire-FirstCall/ -- GlaxoSmithKline Consumer Healthcare (GSK Consumer Healthcare) (NYSE: GSK) has announced advertising agency changes to support growth for global brands. The changes will see GSK Consumer Healthcare partnering with agencies that have comparable market presence to its brands, with a proven ability to roll out world class ideas.

TBWA, part of the Omnicom Group, is appointed GSK's global creative agency for the weight loss brand alli(R) and for the Smoking Control franchise, including Nicorette(R), NicoDerm(R) CQ and Commit(R) sold in the US. TBWA won these global assignments following a rigorous appointment process facilitated by Agency Assessments International. The global creative agency accounts were previously held by Arnold, New York.

Grey currently manages the accounts for a number of GSK's global brands -- Aquafresh(R), Sensodyne(R), Denture Care (Polident(R), Poligrip(R) and Corega(R)) and Breathe Right(R). They have also been awarded TUMS(R), Citrucel(R) and FiberChoice(R) in the US. The agency account for TUMS and Citrucel was previously held by Arnold, New York. The agency account for FiberChoice was previously held by Nelson Henry.

Commenting on the agency assignments, Peter Kirkby, Vice President, Global Marketing Excellence, GSK Consumer Healthcare, said: "GSK Consumer Healthcare has an industry-leading, balanced brand presence in both the world's developed and fastest-growing markets. Our global brands are fundamental to future growth strategy and we want to partner with world class communications agencies with a solid global footprint that can help us drive growth.

"We were enormously impressed by TBWA's passion
'/>"/>

0

GOOD

Page: 1 2
Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine

Post Your Comments:

GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Glo...( TBWA assigned alli and Smoking Contro...),Health